Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
NCT07029412

Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)

Led by MBX Biosciences · Updated on 2025-12-17

10

Participants Needed

4

Research Sites

21 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to assess the preliminary efficacy of single SC administration of MBX 1416 at different dose levels in patients with PBH

CONDITIONS

Official Title

Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 75 years at informed consent
  • Underwent Roux-en-Y gastric bypass or sleeve gastrectomy at least 12 months before study entry
  • Documented history of postbariatric hypoglycemia with symptomatic hypoglycemia, blood glucose ≤54 mg/dL, and symptom improvement after carbohydrate
  • At least one symptomatic hypoglycemic episode per month reported by patient
  • Treatment naive or discontinued medications affecting glucose metabolism before screening
  • Body mass index (BMI) less than 45 kg/m2 at screening
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • History of or current significant illness that may prevent study participation
  • Currently diagnosed with type II diabetes mellitus
  • History of hypoglycemia before bariatric surgery
  • History of insulinoma or other endogenous hyperinsulinemia conditions such as congenital hyperinsulinism

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

MBX Biosciences Investigational Site

Aurora, Colorado, United States, 80045

Actively Recruiting

2

MBX Biosciences Investigational Site

Morehead City, North Carolina, United States, 28557

Actively Recruiting

3

MBX Biosciences Investigational Site

Knoxville, Tennessee, United States, 37920

Actively Recruiting

4

MBX Biosciences Investigational Site

San Antonio, Texas, United States, 78229

Actively Recruiting

Loading map...

Research Team

E

Elisa Fabbrini, MD, PhD

CONTACT

S

Stewart Hallett

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here